A RECENT real-world study highlights the challenges of using the reduced-dose glucocorticoid regimen (redGC) from the PEXIVAS ...

WOMEN with polycystic ovary syndrome (PCOS) have fewer children and give birth later in life compared to women without PCOS, ...

Read on to learn how the impact of chemoradiotherapy for patients receiving neoadjuvant chemoradiotherapy followed by surgery ...

A SYSTEMATIC review investigating the impact of glucagon-like peptide-1 receptor agonists on alcohol consumption has yielded ...

A LARGE-scale trial has recently demonstrated the efficacy of nirmatrelvir/ritonavir (NMV/r), an oral antiviral, in reducing ...

Discover the study that, at week 16, showed how dupilumab demonstrated significant benefits compared to placebo, regardless ...

THE VIBRANT city of Los Angeles, California welcomed over 12,000 clinicians, scientists, epidemiologists, researchers, ...

Rabies is the deadliest infectious disease, with a nearly 100% fatality. Due to this fear, it is often an overlooked disease, ...

IDWEEK 2024, held in Los Angeles, California, October 16th–19th, was an opportunity for the >12,000 attendees to hear ...

Explore how multiple sclerosis affects cancer risk in this 10-year study. Learn about age, gender, and cancer-specific trends ...

Discover how a 70-gene test identifies early-stage breast cancer patients who benefit from extended endocrine therapy, ...

Learn how key predictors like oxygen saturation and BMI inform postoperative risks in OSA patients. New study offers ...